Bio

Christopher Comeau leads the firm’s strategic M&A group. Chris focuses his practice on representing public companies and financial investors in connection with public and private merger and acquisition and minority investment transactions. The public companies Chris represents operate primarily in the consumer, life sciences and medical technology industries. The financial investors Chris represents invest primarily in consumer products and retail brands, services, and manufacturing. Chris has led recent transactions for Medtronic, Signify Health, Shire, Pfizer, Sarepta Therapeutics, TSG Consumer Partners, and Johnson & Johnson. Prior to joining Ropes & Gray, Chris spent three years with Coopers & Lybrand LLP, a predecessor firm to PricewaterhouseCoopers LLP.